Pharmacotherapies for treatment of cocaine abuse: preclinical aspects.
Carroll
F I
FI
Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, North Carolina 27709, USA.
Howell
L L
LL
Kuhar
M J
MJ
D000818:Animals; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D019970:Cocaine-Related Disorders / Q000188:drug therapy* / Q000378:metabolism; D003346:Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D015259:Dopamine Agents / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D018377:Neurotransmitter Agents / Q000378:metabolism / Q000502:physiology*; D011957:Receptors, Opioid / Q000187:drug effects; D018490:Serotonin Agents / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D015259:Dopamine Agents; D018691:Excitatory Amino Acid Antagonists; D018377:Neurotransmitter Agents; D011957:Receptors, Opioid; D018490:Serotonin Agents; D003346:Corticotropin-Releasing Hormone